These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 15500432

  • 1. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.
    Padma V, Fisher M, Moonis M.
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):867-76. PubMed ID: 15500432
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH.
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P, de la Sierra A.
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [Abstract] [Full Text] [Related]

  • 8. [Lowering blood pressure--preventing 4 out of 10 strokes. Fully utilizing antihypertensive therapy].
    Schrader J.
    MMW Fortschr Med; 2000 Jan 13; 142(1-2):22-5. PubMed ID: 11291150
    [Abstract] [Full Text] [Related]

  • 9. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B, Ortega-Casarrubios MA, Martínez P, Díez-Tejedor E.
    Cerebrovasc Dis; 2007 Jan 13; 24 Suppl 1():96-106. PubMed ID: 17971644
    [Abstract] [Full Text] [Related]

  • 10. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA, Ameriso S, Povedano GP, Ameriso SF.
    J Stroke Cerebrovasc Dis; 2012 Nov 13; 21(8):868-72. PubMed ID: 21703876
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB, Dahlöf B.
    Curr Med Res Opin; 2007 Feb 13; 23(2):443-57. PubMed ID: 17288698
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P, Porebska A, Bajer-Czajkowska A, Zywica A, Koziarska D, Podbielski J.
    Ann Acad Med Stetin; 2007 Feb 13; 53(2):14-9. PubMed ID: 18557372
    [Abstract] [Full Text] [Related]

  • 17. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
    Eveson DJ, Robinson TG, Potter JF.
    Am J Hypertens; 2007 Mar 13; 20(3):270-7. PubMed ID: 17324738
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials.
    Segall L, Oprisiu R, Fournier A, Covic A.
    J Nephrol; 2008 Mar 13; 21(3):374-83. PubMed ID: 18587726
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.